News

Researchers have solved the structure of the influenza virus' replication machinery, giving structural insights into new potential drug targets and how the virus adapts to different hosts.

Compounds used to add flavor to drinks, candies and e-cigarette mixes could affect protein functions by binding and altering their shape.

Scientists have used advanced computing technology and artificial intelligence to design a transparent window coating that could lower the temperature inside buildings, without expending a single watt of energy.

Researchers have developed a fast and cost-effective method to test liquids for a ubiquitous family of chemical compounds known as amphiphiles, which are used to detect diseases such as early-stage tuberculosis and cancer as well as to detect toxins in drugs, food, medical devices and water supplies.

COVID-19 infections can result in long-lasting neurological symptoms; new research suggests an already approved anti-viral may inhibit viral replication and rescue impaired neurons.

Researchers in a new study describe the development of an experimental vaccine that could be used to prevent or treat an aggressive form of breast cancer, safely generating an immune response against an important driver of breast cancer growth.

Researchers have discovered the mechanistic steps underlying a new type of synaptic plasticity called behavioral timescale synaptic plasticity.

Researchers have used a computer model to successfully simulate a clinical trial evaluating the efficacy of multiple treatments for Alzheimer's disease.

Researchers have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective.

Scientists have illuminated the molecular events underlying an inherited movement and neurodegenerative disorder known as ARSACS – Autosomal recessive spastic ataxia of Charlevoix-Saguenay, named for two Quebec valleys where the first cases were found.